医学
冲程(发动机)
协议(科学)
急诊医学
医疗急救
急性中风
溶栓
干预(咨询)
纤溶剂
重症监护医学
编码(集合论)
关键路径
相(物质)
梅德林
诊断代码
物理疗法
质量管理
护理标准
卫生服务研究
项目评估
医疗保健
中风恢复
缺血性中风
临床试验
作者
Shayan Alijanpour,Fatemeh Bahramnezhad,Ashkan Mowla,Shahin Shifteh,Zoya Hadinezhad,Soraya Khafri,Nahid Dehghan Nayeri
出处
期刊:Stroke
[Lippincott Williams & Wilkins]
日期:2026-03-04
卷期号:57 (6): 1602-1614
被引量:1
标识
DOI:10.1161/strokeaha.125.053785
摘要
BACKGROUND: Timely management of acute stroke in the emergency medical services setting is critical. Systemic challenges in this phase include the absence of evidence-based standards, inconsistent protocols, and coordination delays. This study aimed to implement and evaluate an updated national stroke protocol in northern Iran. METHODS: This quasi-experimental study evaluated the Iranian Comprehensive Code Stroke Management Program. The intervention group (Babol emergency medical services, n=248) received a multi-faceted empowerment program, while the control group (Mazandaran emergency medical services, n=900) received standard training. Patients’ level outcomes were assessed on prehospital time, monthly intravenous alteplase counts, and administration rates before (March–September 2023) and after the intervention (March–September 2024). RESULTS: Of 1131 suspected stroke codes, 400 (35%) were hospital-confirmed. The intervention significantly reduced most prehospital time intervals (except transport time) and increased the rate of intravenous alteplase administration per hospital-confirmed stroke code from 13.94% preintervention to 39.49% postintervention (absolute increase +25.55%±19.17; P <0.001). Additionally, the mean monthly number of alteplase administrations showed an increasing trend (+4.00±4.64; P =0.07). Conversely, the control group exhibited a significant decrease in the mean number of monthly alteplase administrations (−0.72±0.57; P =0.04) and a nonsignificant reduction in the administration rate (−1.49 percentage points; SD ±6.47; P =0.69). CONCLUSIONS: Implementing the updated protocol was associated with significant reductions in critical time intervals and a near-tripling of the intravenous alteplase administration rate in the intervention group. National evaluation should include long-term functional outcomes to confirm effectiveness and establish its value as a model.
科研通智能强力驱动
Strongly Powered by AbleSci AI